Biotalys Completes Private Placement for New Shares
Biotalys NV (Brussels: BTLS), an innovative Agricultural Technology (AgTech) company specializing in sustainable crop protection solutions, has officially closed a private placement involving the issuance of 5,300,352 new shares. This placement represents about 16.5% of the company’s outstanding shares before the transaction and was accomplished at an issue price of €2.83 per share. This price reflects a discount of 10% compared to the volume weighted average price of the company’s shares over the prior 30 days, illustrating a strategic financial maneuver to raise capital.
Details of the Share Placement Closure
As of the closing date, the new shares have been officially listed on Euronext Brussels. These shares carry similar rights and benefits as well as parity with all existing outstanding shares. The transaction was expertly coordinated by KBC Securities NV, Belfius Bank NV/SA alongside Kepler Cheuvreux SA, and Coöperatieve Rabobank U.A., a testament to Biotalys' commitment to maintaining robust partnerships in the finance sector.
Company Insights and Shareholder Information
In compliance with the Belgian disclosure regulations, the total outstanding share capital of Biotalys is reported at €5,538,755.50. The comprehensive summary indicates a total of 37,457,562 securities currently carrying voting rights. The company currently holds no convertible bonds or non-voting shares, ensuring that existing shareholders may maintain their influence over company decisions. Furthermore, the share distribution includes options for future stock certificates and share units awarded to independent directors under the company's remuneration policy.
About Biotalys and Its Mission
Founded in 2013 as a spin-off from the renowned VIB (Flanders Institute for Biotechnology), Biotalys is dedicated to revolutionizing agricultural practices through its advanced protein-based biocontrol solutions aimed at replacing conventional pesticides. The company's AGROBODY™ technology platform underpins a diverse portfolio of product candidates tailored to combat significant crop threats, enhancing the safe food supply chain from soil to plate. Since its listing on Euronext Brussels in July 2021, Biotalys has established itself as a frontrunner in the agricultural biotechnology landscape.
Further Information
If you seek more details, you can reach out to Toon Musschoot, Head of Investor Relations and Communication. Contact him via telephone at +32 (0)9 274 54 00 or via email at IR@biotalys.com.
Frequently Asked Questions
What kind of company is Biotalys?
Biotalys NV is an Agricultural Technology company focused on developing sustainable protein-based biocontrol solutions for crop protection.
What was the purpose of the recent private placement?
The private placement aimed to raise funds to support Biotalys' innovative initiatives and growth in the agricultural sector.
How many new shares were issued in the private placement?
Biotalys announced the issuance of 5,300,352 new shares as part of the placement.
On which exchange are Biotalys' shares traded?
Biotalys' shares are traded on Euronext Brussels under the ticker symbol BTLS.
Who coordinated the private placement?
The private placement was coordinated by KBC Securities NV, Belfius Bank NV/SA, Kepler Cheuvreux SA, and Coöperatieve Rabobank U.A.
